| Literature DB >> 2671595 |
G V Naccarelli1, R L Rinkenberger, A H Dougherty, D M Fitzgerald.
Abstract
Amiodarone is an extremely effective antiarrhythmic agent for the treatment of both life-threatening ventricular arrhythmias and refractory supraventricular tachyarrhythmias. Subjective minor side effects are common with amiodarone but rarely require discontinuation of therapy and are often handled by dose reduction. Serious end-organ toxicity, including pulmonary fibrosis and drug-induced hepatitis, have been the most common indications for discontinuing amiodarone therapy in these patients.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2671595 DOI： 10.1007/bf03259911
Source DB: PubMed Journal: Med Toxicol Adverse Drug Exp ISSN： 0113-5244